Skip to main content

Table 3 Most significantly associated SNPs identified in the PLINK analysis

From: GWASeq: targeted re-sequencing follow up to GWAS

Chr: Position

rs ID number

Feature

Base change

MAF: Cases (Controls)

Gene (distance to nearest genes)

Uncorrected p-value (0PCs)

FDR corrected (0PCs)

Uncorrected (2PCs)

FDR corrected (2PCs)

9: 5,980,030

Novel

intronic

A to G

0.048(0.065)

KIAA2026

5.323e–008

0.0002117

1.587e–007

0.0005407

10: 8,542,529

Novel

Intergenic

T to G

0.016(0.028)

LINC00708(232261), LINC00709(775047)

3.576e–007

0.0009478

2.461e–007

0.000734

12: 50,554,103

Novel

intronic

A to G

0.026(0.033)

CERS5

2.926e–007

0.0008725

6.119e–007

0.001622

12: 51,243,510

Novel

intronic

A to T

0.049(0.057)

TMPRSS12

7.362e–008

0.0002509

1.104e–007

0.0004388

14: 54,603,486

rs116055771

Intergenic

A to T

0.013(0.022)

BMP4(179,932), CDKN3(260,187)

4.085e–011

3.248e–007

2.014e–010

1.602e–006

15: 33,008,360

Novel

Intergenic

A to C

0.034(0.054)

SCG5(19,062), GREM1(1,845)

6.384e–009

3.046e–005

2.652e–008

0.0001265

15: 33,345,877

Novel

intronic

A to C

0.004(0.011)

FMN1

2.048e–011

2.443e–007

6.591e–011

7.861e–007

18: 46,119,756

Novel

intronic

T to C

0.010(0.021)

CTIF

2.128e–009

1.736e–006

5.41e–010

3.226e–006

18: 46,119,757

rs76590328

intronic

C to T

0.031(0.054)

CTIF

6.103e–013

1.456e–008

1.98e–012

4.724e–008

18: 46,503,254

Novel

intronic

A to G

0.031(0.057)

LOXHD1

2.722e–006

0.006494

4.838e–006

0.01154